Chrysalyne Schmults, MD, on Basal Cell Carcinoma: Treatment Research Update

Posted: Saturday, March 23, 2019

Chrysalyne Schmults, MD, of Brigham and Women’s Hospital, discusses an update on the use of hedgehog pathway inhibitors such as vismodegib and sonidegib in the treatment of basal cell carcinoma and the status of other agents under study for this type of skin cancer.